Effect of Biqi Capsules Combined with Mudan Granules in the Treatment of Lumbar Disc Herniation
Objective:To study the effect of Biqi capsules combined with Mudan granules in treatment of lumbar disc herniation. Methods:A total of 80 patients with lumbar disc herniation admitted to our hospital from January 2022 to December 2022 were randomly divided into control group and observation group,with 40 patients in each group. The control group was treated with Mudan granules,and the observation group was treated with Biqi capsules combined with Mudan granules. The clinical efficacy,symptom score,serum malondialdehyde (MDA),prostaglandin E2 (PGE2),superoxide dismutase (SOD) and 5-hydroxytryptamine (5-HT) levels were compared between the two groups. Results:After treatment,the total effective rate of the observation group was higher than that of the control group (P<0.05). The scores of low back pain,lumbar activity limitation,lumbar and knee weakness and lower limb pain in the observation group were lower than those in the control group (P<0.05). The serum SOD level in the observation group was higher than that before treatment,and the levels of PGE2,MDA and 5-HT were lower than those in the control group (P<0.05). Conclusion:Biqi capsule combined with Mudan granule has a better effect in the treatment of lumbar disc herniation,which can significantly reduce symptoms,regulate inflammatory factors and oxidative stress levels.